Boniva

Boniva® (Ibandronate Sodium)

Boniva® (Ibandronate Sodium) is used to treat and prevent osteoporosis in postmenopausal women. It is administered intravenously approximately every three months. Doing so may help reduce bone loss for up to five years. Whether to continue with infusion therapy after five years depends on the patient’s medical history and specific needs.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

MANUFACTURER:

Roche Therapeutics Inc.

CLASS:
Calcium Metabolism Modifiers; Bisphosphonate Derivatives.
WHAT IT TREATS:

Osteoporosis

PRESCRIBED BY:

Rheumatologists

HOW ADMINISTERED:
IV Injection
FREQUENCY:

1 every 3 months

Length of infusion:
N/A
FOR MORE INFORMATION: